000			01610 a2200421 4500
005			20250517030806.0
264		0	_c20150720
008			201507s 0 0 eng d
022			_a1879-3169
024	7		_a10.1016/j.toxlet.2015.03.017 _2doi
040			_aNLM _beng _cNLM
100	1		_aBauden, Monika
245	0	0	_aIn vitro cytotoxicity evaluation of HDAC inhibitor Apicidin in pancreatic carcinoma cells subsequent time and dose dependent treatment. _h[electronic resource]
260			_bToxicology letters _cJul 2015
300			_a8-15 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aCarcinoma _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aDNA, Neoplasm _xmetabolism
650	0	4	_aHistone Deacetylase Inhibitors _xpharmacology
650	0	4	_aHistone Deacetylases _xchemistry
650	0	4	_aHumans
650	0	4	_aInhibitory Concentration 50
650	0	4	_aKinetics
650	0	4	_aMitochondria _xdrug effects
650	0	4	_aMycotoxins _xpharmacology
650	0	4	_aNeoplasm Proteins _xantagonists & inhibitors
650	0	4	_aPancreatic Neoplasms _xdrug therapy
650	0	4	_aPeptides, Cyclic _xpharmacology
650	0	4	_aReproducibility of Results
700	1		_aTassidis, Helena
700	1		_aAnsari, Daniel
773	0		_tToxicology letters _gvol. 236 _gno. 1 _gp. 8-15
856	4	0	_uhttps://doi.org/10.1016/j.toxlet.2015.03.017 _zAvailable from publisher's website
999			_c24846415 _d24846415